Cero Therapeutics Holdings, Stock Market Value
| CERO Stock | 0.07 0 4.00% |
| Symbol | CERo |
CERo Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CERo Therapeutics. If investors know CERo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CERo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CERo Therapeutics is measured differently than its book value, which is the value of CERo that is recorded on the company's balance sheet. Investors also form their own opinion of CERo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CERo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CERo Therapeutics' market value can be influenced by many factors that don't directly affect CERo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CERo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CERo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CERo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CERo Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CERo Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CERo Therapeutics.
| 06/28/2025 |
| 12/25/2025 |
If you would invest 0.00 in CERo Therapeutics on June 28, 2025 and sell it all today you would earn a total of 0.00 from holding CERo Therapeutics Holdings, or generate 0.0% return on investment in CERo Therapeutics over 180 days. CERo Therapeutics is related to or competes with Liminatus Pharma,, XORTX Therapeutics, Galmed Pharmaceuticals, Biovie, Elevai Labs,, BriaCell Therapeutics, and Moolec Science. CERo Therapeutics is entity of United States More
CERo Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CERo Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CERo Therapeutics Holdings, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 115.3 | |||
| Value At Risk | (21.43) | |||
| Potential Upside | 20.6 |
CERo Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CERo Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CERo Therapeutics' standard deviation. In reality, there are many statistical measures that can use CERo Therapeutics historical prices to predict the future CERo Therapeutics' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (2.85) | |||
| Total Risk Alpha | (4.45) | |||
| Treynor Ratio | (0.69) |
CERo Therapeutics Backtested Returns
CERo Therapeutics secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14 % return per unit of risk over the last 3 months. CERo Therapeutics Holdings, exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CERo Therapeutics' mean deviation of 10.86, and Risk Adjusted Performance of (0.09) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 3.74, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CERo Therapeutics will likely underperform. At this point, CERo Therapeutics has a negative expected return of -2.64%. Please make sure to confirm CERo Therapeutics' total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if CERo Therapeutics performance from the past will be repeated in the future.
Auto-correlation | 0.61 |
Good predictability
CERo Therapeutics Holdings, has good predictability. Overlapping area represents the amount of predictability between CERo Therapeutics time series from 28th of June 2025 to 26th of September 2025 and 26th of September 2025 to 25th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CERo Therapeutics price movement. The serial correlation of 0.61 indicates that roughly 61.0% of current CERo Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.61 | |
| Spearman Rank Test | 0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 3.65 |
CERo Therapeutics lagged returns against current returns
Autocorrelation, which is CERo Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CERo Therapeutics' stock expected returns. We can calculate the autocorrelation of CERo Therapeutics returns to help us make a trade decision. For example, suppose you find that CERo Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CERo Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CERo Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CERo Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CERo Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
CERo Therapeutics Lagged Returns
When evaluating CERo Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CERo Therapeutics stock have on its future price. CERo Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CERo Therapeutics autocorrelation shows the relationship between CERo Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in CERo Therapeutics Holdings,.
Regressed Prices |
| Timeline |
Pair Trading with CERo Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CERo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with CERo Stock
Moving against CERo Stock
| 0.85 | VCEL | Vericel Corp Ord | PairCorr |
| 0.85 | VKTX | Viking Therapeutics | PairCorr |
| 0.75 | VCYT | Veracyte | PairCorr |
| 0.69 | DNLI | Denali Therapeutics | PairCorr |
| 0.6 | DSGN | Design Therapeutics | PairCorr |
The ability to find closely correlated positions to CERo Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CERo Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CERo Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CERo Therapeutics Holdings, to buy it.
The correlation of CERo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CERo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CERo Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CERo Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out CERo Therapeutics Correlation, CERo Therapeutics Volatility and CERo Therapeutics Alpha and Beta module to complement your research on CERo Therapeutics. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
CERo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.